| Primary |
| Depression |
37.1% |
| Anxiety |
10.3% |
| Bipolar Disorder |
10.3% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Sleep Disorder |
4.1% |
| Hypertension |
3.1% |
| Major Depression |
3.1% |
| Memory Impairment |
3.1% |
| Somatisation Disorder |
3.1% |
| Anxiolytic Therapy |
2.1% |
| Blood Cholesterol |
2.1% |
| Blood Pressure |
2.1% |
| Lung Disorder |
2.1% |
| Mood Altered |
2.1% |
| Osteoarthritis |
2.1% |
| Pain |
2.1% |
| Panic Attack |
2.1% |
| Panic Disorder |
2.1% |
| Vomiting |
2.1% |
| Agitation |
1.0% |
|
| Speech Disorder |
9.1% |
| Suicidal Ideation |
9.1% |
| Visual Impairment |
9.1% |
| Mania |
6.1% |
| Off Label Use |
6.1% |
| Tremor |
6.1% |
| Urinary Tract Infection |
6.1% |
| Vision Blurred |
6.1% |
| Vomiting |
6.1% |
| Withdrawal Syndrome |
6.1% |
| Aortic Aneurysm |
3.0% |
| Bezoar |
3.0% |
| Breast Cancer |
3.0% |
| Breast Cancer Metastatic |
3.0% |
| Cardiomyopathy |
3.0% |
| Cerebral Haemorrhage |
3.0% |
| Death |
3.0% |
| Dementia |
3.0% |
| Dengue Fever |
3.0% |
| Diplegia |
3.0% |
|
| Secondary |
| Depression |
28.1% |
| Bipolar Disorder |
23.8% |
| Anxiety |
6.3% |
| Sleep Disorder |
6.3% |
| Generalised Anxiety Disorder |
3.8% |
| Panic Disorder |
3.8% |
| Post-traumatic Stress Disorder |
3.1% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Major Depression |
2.5% |
| Neuralgia |
2.5% |
| Quadriplegia |
2.5% |
| Anxiolytic Therapy |
1.9% |
| Mood Altered |
1.9% |
| Obsessive-compulsive Disorder |
1.9% |
| Prolactinoma |
1.9% |
| Social Phobia |
1.9% |
| Somatisation Disorder |
1.9% |
| Antidepressant Therapy |
1.3% |
| Lung Disorder |
1.3% |
| Prostate Cancer |
1.3% |
|
| Suicidal Ideation |
15.1% |
| Off Label Use |
9.4% |
| Mental Disorder |
7.5% |
| Tremor |
7.5% |
| Weight Increased |
7.5% |
| Sedation |
5.7% |
| Syncope |
5.7% |
| Toxicity To Various Agents |
5.7% |
| Uterine Disorder |
5.7% |
| Mania |
3.8% |
| Neurodegenerative Disorder |
3.8% |
| Ocular Hyperaemia |
3.8% |
| Speech Disorder |
3.8% |
| Suffocation Feeling |
3.8% |
| Bezoar |
1.9% |
| Disease Progression |
1.9% |
| Drug Ineffective |
1.9% |
| Haemorrhage |
1.9% |
| Headache |
1.9% |
| Hepatic Steatosis |
1.9% |
|
| Concomitant |
| Depression |
15.5% |
| Pain |
10.5% |
| Fibromyalgia |
5.5% |
| Schizophrenia |
5.5% |
| Anxiety |
5.0% |
| Diabetes Mellitus |
4.5% |
| Multiple Sclerosis |
4.5% |
| Product Used For Unknown Indication |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Blood Cholesterol |
4.0% |
| Insomnia |
4.0% |
| Neuropathy Peripheral |
4.0% |
| Osteoporosis |
4.0% |
| Clonic Convulsion |
3.5% |
| Extrapyramidal Disorder |
3.5% |
| Gastrooesophageal Reflux Disease |
3.5% |
| Infection |
3.5% |
| Pneumonia |
3.5% |
| Skin Ulcer |
3.5% |
| Antidepressant Therapy |
3.0% |
|
| Wound |
15.7% |
| Drug Ineffective |
11.8% |
| Weight Decreased |
11.8% |
| Vomiting |
9.8% |
| Visual Impairment |
5.9% |
| Death |
3.9% |
| Irritability |
3.9% |
| Nightmare |
3.9% |
| Respiratory Failure |
3.9% |
| Tachycardia |
3.9% |
| Throat Irritation |
3.9% |
| Urticaria |
3.9% |
| Weight Increased |
3.9% |
| Burning Sensation |
2.0% |
| Chest Pain |
2.0% |
| Circulatory Collapse |
2.0% |
| Diarrhoea |
2.0% |
| Diverticulitis |
2.0% |
| Feeling Abnormal |
2.0% |
| Gastric Ulcer |
2.0% |
|
| Interacting |
| Anxiety |
13.0% |
| Bipolar Disorder |
8.7% |
| Depression |
8.7% |
| Panic Attack |
8.7% |
| Sleep Disorder Therapy |
8.7% |
| Thyroiditis |
8.7% |
| Alpha-1 Anti-trypsin Deficiency |
4.3% |
| Altered Mood |
4.3% |
| Attention Deficit/hyperactivity Disorder |
4.3% |
| Back Disorder |
4.3% |
| Cholesterol |
4.3% |
| Chronic Myeloid Leukaemia |
4.3% |
| Hormone Replacement Therapy |
4.3% |
| Hypertension |
4.3% |
| Mood Disorder Nos |
4.3% |
| Smoking Cessation Therapy |
4.3% |
|
| Increased Appetite |
16.7% |
| Serotonin Syndrome |
16.7% |
| Sleep Disorder |
16.7% |
| Suicide Attempt |
16.7% |
| Trismus |
16.7% |
| Visual Impairment |
16.7% |
|
